Top

Published in:

Open Access 01-12-2008 | Research

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile

Authors: François Ducray, Ahmed Idbaih, Aurélien de Reyniès, Ivan Bièche, Joëlle Thillet, Karima Mokhtari, Séverine Lair, Yannick Marie, Sophie Paris, Michel Vidaud, Khê Hoang-Xuan, Olivier Delattre, Jean-Yves Delattre, Marc Sanson

Published in: Molecular Cancer | Issue 1/2008

Abstract

Background

In high grade gliomas, 1p19q codeletion and EGFR amplification are mutually exclusive and predictive of dramatically different outcomes. We performed a microarray gene expression study of four high grade gliomas with 1p19q codeletion and nine with EGFR amplification, identified by CGH-array.

Results

The two groups of gliomas exhibited very different gene expression profiles and were consistently distinguished by unsupervised clustering analysis. One of the most striking differences was the expression of normal brain genes by oligodendrogliomas with 1p19q codeletion. These gliomas harbored a gene expression profile that partially resembled the gene expression of normal brain samples, whereas gliomas with EGFR amplification expressed many genes in common with glioblastoma cancer stem cells. The differences between the two types of gliomas and the expression of neuronal genes in gliomas with 1p19q codeletion were both validated in an independent series of 16 gliomas using real-time RT-PCR with a set of 22 genes differentiating the two groups of gliomas (AKR1C3, ATOH8, BMP2, C20orf42, CCNB1, CDK2, CHI3L1, CTTNBP2, DCX, EGFR, GALNT13, GBP1, IGFBP2, IQGAP1, L1CAM, NCAM1, NOG, OLIG2, PDPN, PLAT, POSTN, RNF135). Immunohistochemical study of the most differentially expressed neuronal gene, alpha-internexin, clearly differentiated the two groups of gliomas, with 1p19q codeletion gliomas showing specific staining in tumor cells.

Conclusion

These findings provide evidence for neuronal differentiation in oligodendrogliomas with 1p19q codeletion and support the hypothesis that the cell of origin for gliomas with 1p19q codeletion could be a bi-potential progenitor cell, able to give rise to both neurons and oligodendrocytes.

Available only for authorised users

Idbaih A, Marie Y, Pierron G, Brennetot C, Hoang-Xuan K, Kujas M, Mokhtari K, Sanson M, Lejeune J, Aurias A, Delattre O, Delattre JY: Two types of chromosome 1p losses with opposite significance in gliomas. Ann Neurol. 2005, 58 (3): 483-487. 10.1002/ana.20607CrossRefPubMed

Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM, Law M, Flynn H, Passe S, Felten S, Brown PD, Shaw EG, Buckner JC: A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res. 2006, 66 (20): 9852-9861. 10.1158/0008-5472.CAN-06-1796CrossRefPubMed

Idbaih A, Marie Y, Lucchesi C, Pierron G, Manie E, Raynal V, Mosseri V, Hoang-Xuan K, Kujas M, Brito I, Mokhtari K, Sanson M, Barillot E, Aurias A, Delattre JY, Delattre O: BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas. Int J Cancer. 2008, 122 (8): 1778-1786. 10.1002/ijc.23270CrossRefPubMed

Dehais C, Laigle-Donadey F, Marie Y, Kujas M, Lejeune J, Benouaich-Amiel A, Pedretti M, Polivka M, Xuan KH, Thillet J, Delattre JY, Sanson M: Prognostic stratification of patients with anaplastic gliomas according to genetic profile. Cancer. 2006, 107 (8): 1891-1897. 10.1002/cncr.22211CrossRefPubMed

Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K: Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006, 9 (3): 157-173. 10.1016/j.ccr.2006.02.019CrossRefPubMed

Gene Expression Omnibus repository (GSE7307) (http://www.ncbi.nlm.nih.gov/geo).

Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, Aigner L, Brawanski A, Bogdahn U, Beier CP: CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 2007, 67 (9): 4010-4015. 10.1158/0008-5472.CAN-06-4180CrossRefPubMed

ArrayExpress: http://www.ebi.ac.uk/arrayexpress.

Bioconductor: version 2.0, http://www.bioconductor.org.

10.

Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP: Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003, 31 (4): e15- 10.1093/nar/gng015PubMedCentralCrossRefPubMed

11.

Boyault S, Rickman DS, de Reynies A, Balabaud C, Rebouissou S, Jeannot E, Herault A, Saric J, Belghiti J, Franco D, Bioulac-Sage P, Laurent-Puig P, Zucman-Rossi J: Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology. 2007, 45 (1): 42-52. 10.1002/hep.21467CrossRefPubMed

12.

Simon R, Peng-Lam A: BRB Array Tools (version 3.5.0), http://linus.nci.nih.gov/BRB-ArrayTools.html.

13.

GSEA: v2.0 software. http://www.broad.mit.edu/gsea.

14.

Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005, 102 (43): 15545-15550. 10.1073/pnas.0506580102PubMedCentralCrossRefPubMed

15.

Affymetrix: annotation file HG-U133_Plus_2.annot.csv. http://www.affymetrix.com. 2007.

16.

TheGeneOntology: http://www.geneontology.org. 2007.

17.

GOA: Gene Ontology Database. ftp://ftp.ebi.ac.uk/pub/databases/GO/goa.

18.

DAVID: National Institute of Allergy and Infectious Diseases (NIAID), NIH. http://david.abcc.ncifcrf.gov/. 2008.

19.

Bieche I, Parfait B, Le Doussal V, Olivi M, Rio MC, Lidereau R, Vidaud M: Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. Cancer Res. 2001, 61 (4): 1652-1658.PubMed

20.

Novocastra: http://www.leica-microsystems.com/Histology_Systems, product code : NCL-A-INTER, clone 2E3.

21.

Couillard-Despres S, Winner B, Schaubeck S, Aigner R, Vroemen M, Weidner N, Bogdahn U, Winkler J, Kuhn HG, Aigner L: Doublecortin expression levels in adult brain reflect neurogenesis. Eur J Neurosci. 2005, 21 (1): 1-14. 10.1111/j.1460-9568.2004.03813.xCrossRefPubMed

22.

Zhang Y, Iwasaki H, Wang H, Kudo T, Kalka TB, Hennet T, Kubota T, Cheng L, Inaba N, Gotoh M, Togayachi A, Guo J, Hisatomi H, Nakajima K, Nishihara S, Nakamura M, Marth JD, Narimatsu H: Cloning and characterization of a new human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen. J Biol Chem. 2003, 278 (1): 573-584. 10.1074/jbc.M203094200CrossRefPubMed

23.

Inoue C, Bae SK, Takatsuka K, Inoue T, Bessho Y, Kageyama R: Math6, a bHLH gene expressed in the developing nervous system, regulates neuronal versus glial differentiation. Genes Cells. 2001, 6 (11): 977-986. 10.1046/j.1365-2443.2001.00476.xCrossRefPubMed

24.

Steele-Perkins G, Plachez C, Butz KG, Yang G, Bachurski CJ, Kinsman SL, Litwack ED, Richards LJ, Gronostajski RM: The transcription factor gene Nfib is essential for both lung maturation and brain development. Mol Cell Biol. 2005, 25 (2): 685-698. 10.1128/MCB.25.2.685-698.2005PubMedCentralCrossRefPubMed

25.

Kasai M, Satoh K, Akiyama T: Wnt signaling regulates the sequential onset of neurogenesis and gliogenesis via induction of BMPs. Genes Cells. 2005, 10 (8): 777-783. 10.1111/j.1365-2443.2005.00876.xCrossRefPubMed

26.

Lim DA, Tramontin AD, Trevejo JM, Herrera DG, Garcia-Verdugo JM, Alvarez-Buylla A: Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron. 2000, 28 (3): 713-726. 10.1016/S0896-6273(00)00148-3CrossRefPubMed

27.

Mabie PC, Mehler MF, Marmur R, Papavasiliou A, Song Q, Kessler JA: Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial-astroglial progenitor cells. J Neurosci. 1997, 17 (11): 4112-4120.PubMed

28.

Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF: Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 2004, 64 (18): 6503-6510. 10.1158/0008-5472.CAN-04-0452CrossRefPubMed

29.

Chan SO, Chiu FC: Cloning and developmental expression of human 66 kd neurofilament protein. Brain Res Mol Brain Res. 1995, 29 (1): 177-184. 10.1016/0169-328X(94)00268-JCrossRefPubMed

30.

Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK, Lamborn KR, Berger MS, Botstein D, Brown PO, Israel MA: Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A. 2005, 102 (16): 5814-5819. 10.1073/pnas.0402870102PubMedCentralCrossRefPubMed

31.

Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN: Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res. 2003, 63 (7): 1602-1607.PubMed

32.

French PJ, Swagemakers SM, Nagel JH, Kouwenhoven MC, Brouwer E, van der Spek P, Luider TM, Kros JM, van den Bent MJ, Sillevis Smitt PA: Gene expression profiles associated with treatment response in oligodendrogliomas. Cancer Res. 2005, 65 (24): 11335-11344. 10.1158/0008-5472.CAN-05-1886CrossRefPubMed

33.

Mukasa A, Ueki K, Ge X, Ishikawa S, Ide T, Fujimaki T, Nishikawa R, Asai A, Kirino T, Aburatani H: Selective expression of a subset of neuronal genes in oligodendroglioma with chromosome 1p loss. Brain Pathol. 2004, 14 (1): 34-42.CrossRefPubMed

34.

Mukasa A, Ueki K, Matsumoto S, Tsutsumi S, Nishikawa R, Fujimaki T, Asai A, Kirino T, Aburatani H: Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p. Oncogene. 2002, 21 (25): 3961-3968. 10.1038/sj.onc.1205495CrossRefPubMed

35.

Tews B, Felsberg J, Hartmann C, Kunitz A, Hahn M, Toedt G, Neben K, Hummerich L, von Deimling A, Reifenberger G, Lichter P: Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling. Int J Cancer. 2006, 119 (4): 792-800. 10.1002/ijc.21901CrossRefPubMed

36.

Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA: Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closelymirror the phenotype and genotype of primary tumors than do serum-cultured celllines. Cancer Cell. 2006, 9 (5): 391-403. 10.1016/j.ccr.2006.03.030CrossRefPubMed

37.

Horvath S, Zhang B, Carlson M, Lu KV, Zhu S, Felciano RM, Laurance MF, Zhao W, Qi S, Chen Z, Lee Y, Scheck AC, Liau LM, Wu H, Geschwind DH, Febbo PG, Kornblum HI, Cloughesy TF, Nelson SF, Mischel PS: Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A. 2006, 103 (46): 17402-17407. 10.1073/pnas.0608396103PubMedCentralCrossRefPubMed

38.

Jenkinson MD, du Plessis DG, Smith TS, Joyce KA, Warnke PC, Walker C: Histological growth patterns and genotype in oligodendroglial tumours:correlation with MRI features. Brain. 2006, 129: 1884-1891. 10.1093/brain/awl108CrossRefPubMed

39.

Vyberg M, Ulhøi BP, Teglbjaerg PS: Neuronal features of oligodendrogliomas-an ultrastructural and immunohistochemical study. Histopathology. 2007, 50: 887-896. 10.1111/j.1365-2559.2007.02686.xCrossRefPubMed

40.

Menn B, Garcia-Verdugo JM, Yaschine C, Gonzalez-Perez O, Rowitch D, Alvarez-Buylla A: Origin of oligodendrocytes in the subventricular zone of the adult brain. J Neurosci. 2006, 26 (30): 7907-7918. 10.1523/JNEUROSCI.1299-06.2006CrossRefPubMed

41.

Nunes MC, Roy NS, Keyoung HM, Goodman RR, McKhann G, Jiang L, Kang J, Nedergaard M, Goldman SA: Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med. 2003, 9 (4): 439-447. 10.1038/nm837CrossRefPubMed

42.

Sim FJ, Lang JK, Waldau B, Roy NS, Schwartz TE, Pilcher WH, Chandross KJ, Natesan S, Merrill JE, Goldman SA: Complementary patterns of gene expression by human oligodendrocyte progenitors and their environment predict determinants of progenitor maintenance and differentiation. Ann Neurol. 2006, 56 (1): 773-9. 10.1200/JCO.2005.02.2194

43.

Parras CM, Hunt C, Sugimori M, Nakafuku M, Rowitch D, Guillemot F: The proneural gene Mash1 specifies an early population of telencephalic oligodendrocytes. J Neurosci. 2007, 27 (16): 4233-4242. 10.1523/JNEUROSCI.0126-07.2007CrossRefPubMed

44.

Sugimori M, Nagao M, Parras CM, Nakatani H, Lebel M, Guillemot F, Nakafuku M: Ascl1 is required for oligodendrocyte development in the spinal cord. Development. 2008, 135 (7): 1271-1281. 10.1242/dev.015370CrossRefPubMed

45.

Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, Rowitch DH: Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell. 2002, 109 (1): 75-86. 10.1016/S0092-8674(02)00678-5CrossRefPubMed

Title: Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile
Authors: François Ducray
Ahmed Idbaih
Aurélien de Reyniès
Ivan Bièche
Joëlle Thillet
Karima Mokhtari
Séverine Lair
Yannick Marie
Sophie Paris
Michel Vidaud
Khê Hoang-Xuan
Olivier Delattre
Jean-Yves Delattre
Marc Sanson
Publication date: 01-12-2008
Publisher: BioMed Central
Published in: Molecular Cancer / Issue 1/2008
Electronic ISSN: 1476-4598
DOI: https://doi.org/10.1186/1476-4598-7-41

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2008

Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma

Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells

Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers

Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells

DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update

Tuberin haploinsufficiency is associated with the loss of OGG1 in rat kidney tumors

Keynote webinar | Spotlight on antibody–drug conjugates in cancer